Pandemic-related disruptions in cancer screening showed an uneven recovery in 2023, data from the National Health Interview ...

Researchers examined screening rates for three kinds of cancer before, during, and after the COVID-19 pandemic.

Despite a proven survival benefit, the addition of pembrolizumab (Keytruda) to chemoradiotherapy for newly diagnosed locally ...

A new government report says that rates for precancerous lesions decreased about 80% among younger women who were screened ...

Breast and colon cancer screening numbers have since rebounded and have even surpassed pre-pandemic screening estimates, a ...

Bandi and her team found that past-year cervical cancer screenings in 2023 remained at 14%, which is below pre-pandemic ...

From 2008 to 2022, the incidence of cervical precancers fell by 80% among screened women aged 20 to 24 years, supporting ...

A recent CDC report further demonstrates the effectiveness of the HPV vaccine against cervical cancer. HPV is a sexually ...

Colorectal cancer screening increased 12% and breast cancer screening increased 7% between 2019 and 2023. Cervical cancer screening remained 14% below rates from 2019, neither increasing or decreasing ...

As part of the Ontario Cervical Screening Program, the province has announced it is going to use Human Papillomavirus (HPV) testing rather than Pap smear tests as a primary way to screen for cervical ...

Cervical cancer incidence is rising, with rural and minoritized populations experiencing worse outcomes due to suboptimal ...